We are a tightly-knit, San Francisco based biotech committed to developing effective, prolonging products for dogs and cats. We are pet-lovers that share a common goal of keeping pets happy, healthy, and living longer.
OKAVA was founded by accomplished industry executives with a proven track record bringing innovative human products to market.
Copyright © 2024 Okava Pharmaceuticals. All rights reserved.
Dr. Klotsman has over 20 years of diverse industry experience.He began his career at GlaxoSmithKline where he held numerous roles.Prior to starting Okava, Michael ran his own consultancy where he served as C-suite advisor to privately and publicly held biotech companies.Michael was then recruited to a preeminent strategy consulting firm renowned for its expertise in strategic decision-making, risk management, and shareholder value creation.Michael has a B.A. in Biochemistry & Molecular Biology, holds a MPH from the University of Michigan, a MBA. from Duke University, and a PhD from the University of North Carolina at Chapel Hill.
Dr. Anderson’s career spans over 30 years.Dr. Anderson earned his PhD in Pharmacology.He retired from GSK as the worldwide Wide Director of Respiratory Research and currently has appointments as a research associate professor in the Department of Medicine and an adjunct associate professor in the School of Pharmacy, both at the University of North Carolina, Chapel Hill.
He earned his VMD from the University of Pennsylvania and his JD from Seton Hall.Dr. Petrick is an animal health industry veteran with over 30 years in regulatory affairs.He was the former head of regulatory affairs at Schering-Plough Animal Health (currently Merck Animal Health).
Dr. Ringold is a biotechnology entrepreneur and currently serves as the CEO of Quadriga.From 1991 to 2000, Gordon was CEO of Affymax Research Institute (acquired by Glaxo).From 1997 to 2015, he served in various capacities as Co-Founder and/or CEO of Maxygen, SurroMed, Alexza, and Alavita.Gordon received his PhD in the laboratory of Nobel Laureate Dr. Harold Varmus, before joining the Stanford University School of Medicine where he invented technologies that are now widely used for production of dozens of therapeutic products.
Ms. Stephanus is an industry leader in animal health with over 30 years of experience.Former roles include Chief Commercial Officer of Aratana, founder and CEO of Summit VetPharm (now CEVA), and Head of Global Marketing for Pfizer (now Zoetis).